Page last updated: 2024-08-24

imiquimod and albendazole

imiquimod has been researched along with albendazole in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Colantoni, A; Di Fusco, D; Di Grazia, A; Dinallo, V; Laudisi, F; Marafini, I; Monteleone, G; Monteleone, I; Stolfi, C1

Other Studies

2 other study(ies) available for imiquimod and albendazole

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Albendazole negatively regulates keratinocyte proliferation.
    Clinical science (London, England : 1979), 2020, 04-17, Volume: 134, Issue:7

    Topics: Albendazole; Animals; cdc25 Phosphatases; Cell Line; Cell Proliferation; Cytokines; Dermatologic Agents; Disease Models, Animal; eIF-2 Kinase; Eukaryotic Initiation Factor-2; Humans; Imiquimod; Inflammation Mediators; Keratinocytes; Keratins; Male; Mice, Inbred C57BL; Phosphorylation; Psoriasis; S Phase Cell Cycle Checkpoints; Signal Transduction; Skin

2020